Evidence map›Paper›PMID 37832713›Full record

ArticleProgress in neurobiology2023

Adverse and compensatory neurophysiological slowing in Parkinson's disease.

Alex I Wiesman, Jason da Silva Castanheira, Clotilde Degroot, Edward A Fon, Sylvain Baillet, PREVENT-AD Research Group, Quebec Parkinson Network

Open access · greenAbstract read
In one paragraph

Article in Progress in neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Clinical utility and prospective of TMS-EEG: Updated review from an international expert group.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cortical Effects of Dopamine Replacement Account for Clinical Response Variability in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Dysfunction of motor cortices in Parkinson's disease.Cerebral cortex (New York, N.Y. : 1991) · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alex I WiesmanMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada. Electronic address: alexander.wiesman@mcgill.ca.
Jason da Silva CastanheiraMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Clotilde DegrootMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Edward A FonMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Sylvain BailletMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada. Electronic address: sylvain.baillet@mcgill.ca.
PREVENT-AD Research GroupMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Quebec Parkinson NetworkMcConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Montreal Neurological Institute and Hospital · CAMcGill University · CA

Funding

BrainStorm: Highly Extensible Software for Advanced Electrophysiology and MEG/EEG ImagingR01EB026299 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LEAHY, RICHARD M · 2018 to 2025
$5.4M
Characterizing the interaction between neural attention and somato-motor systems in non-demented patients with Parkinson's diseaseF32NS119375 · NINDS · MCGILL UNIVERSITY · PI WIESMAN, ALEX I · 2020 to 2023
$205k
NIBIB NIH HHS R01 EB026299NINDS NIH HHS F32 NS119375
6 · The paper itself

Abstract

Patients with Parkinson's disease (PD) exhibit multifaceted changes in neurophysiological brain activity, hypothesized to represent a global cortical slowing effect. Using task-free magnetoencephalography and extensive clinical assessments, we found that neurophysiological slowing in PD is differentially associated with motor and non-motor symptoms along a sagittal gradient over the cortical anatomy. In superior parietal regions, neurophysiological slowing reflects an adverse effect and scales with cognitive and motor impairments, while across the inferior frontal cortex, neurophysiological slowing is compatible with a compensatory role. This adverse-to-compensatory gradient is sensitive to individual clinical profiles, such as drug regimens and laterality of symptoms; it is also aligned with the topography of neurotransmitter and transporter systems relevant to PD. We conclude that neurophysiological slowing in patients with PD signals both deleterious and protective mechanisms of the disease, from posterior to anterior regions across the cortex, respectively, with functional and clinical relevance to motor and cognitive symptoms.

Indexed as

Parkinson DiseaseFrontal LobeHumansMagnetoencephalographyParietal LobeFunctional gradientNeurophysiological slowingParkinson’s diseaseSpectral parameterization

Identifiers

PMID37832713
PMCPMC10872886
OpenAlexW4387523705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.